Pill for type 2 diabetes may control diabetic eye disease Boehringer Ingelheim and Eli Lilly’s oral diabetes drug Jardiance may keep diabetic eye disease from worsening in patients with type 2 ...

To receive the full newsletter in your inbox for free sign up here, opens new tab) The Johnson & Johnson (JNJ.N), opens new tab drug Darzalex ... patient had received Jardiance, a pill from ...

India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

(Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential ... but it became the first SGLT2 drug to be approved for CKD in diabetics last October ...

Boehringer and Eli Lilly have started a large-scale trial of their diabetes drug Jardiance in acute heart failure, seeking to get ahead of rivals such as AstraZeneca. The new study - called ...

Aetna alleges generic drugmakers colluded to inflate prices of essential medications, with increases reaching as high as 2,762%. The lawsuit claims a "fair share" market allocation system and ...

SEATTLE — Sen. Patty Murray held a press conference Thursday in light of a cap on prescription drug costs for some on Medicare going into effect. Out-of-pocket costs for prescription medications ...